Abstract: This invention relates a method of combining an amino acid, with one of an elemental calcium, potassium, sodium, zinc and magnesium ion as an oral supplement for the purpose of passing the amino acid through the blood brain barrier for the delivery of specific amino acids with a higher PH, for enhancing athletic performance, for reducing fat, and/or as an anti-aging agent.

Abstract: This invention relates a method of orally administering surfactant and solubilizing agent compounds to a human or animal for the purpose of emulsifying drugs/natural compounds to increase absorption into the body.

Abstract: This invention relates a method of orally administering a liquid consisting of a combination of nitrogen based compounds consisting of nitrogen, nitric oxide or nitrous oxide with amino acids and/or amino acid peptides salts and esters and stimulants and stimulant salts to increase athletic performance, anti-aging focus, and energy output, and a method of administering a combination of combining hydrogen compounds, consisting of hydrogen gases and/or ions including but not limited to H2 and H+ signaling molecules with both D and L forms of amino acids and/or amino acid peptides salts and esters, and stimulants and stimulant salts for providing increased athletic performance via hydration, for increased energy output, and for the reduction of free radical damage.

Abstract: A method for the use of derivatives of hydroxyprogesterone (17-alpha-hydroxypregn-4-ene-3,20-dione) to enhance health and physical performance in humans and more particularly to the use of hydroxyprogesterone derivatives for restoring renal hormonal balance, decreasing body weight, reducing adipose tissue, increasing endurance, promoting skeletal muscle growth, boosting androgen levels, inhibiting aromatase, and increasing cognitive function.

Abstract: A method is disclosed for administering a DHEA derivative or a physiologically acceptable salt, ester or ether thereof for one of decreasing body weight, reducing adipose tissue, increasing endurance, as an anti-aging compound and generating production of red blood cells.

Abstract: A method is disclosed for administering a DHEA derivative or a physiologically acceptable salt, ester or ether thereof for one of decreasing body weight, reducing adipose tissue, increasing endurance, as an anti-aging compound and generating production of red blood cells.

Abstract: A method is disclosed for administering a DHEA derivative or a physiologically acceptable salt, ester or ether thereof for one of decreasing body weight, reducing adipose tissue, increasing endurance, as an anti-aging compound and generating production of red blood cells.

Abstract: A method is disclosed for administering a DHEA derivative or a physiologically acceptable salt, ester or ether thereof for one of decreasing body weight, reducing adipose tissue, increasing endurance, as an anti-aging compound and generating production of red blood cells.

Abstract: A method is disclosed for administering a DHEA derivative or a physiologically acceptable salt, ester or ether thereof for one of decreasing body weight, reducing adipose tissue, increasing endurance, as an anti-aging compound and generating production of red blood cells.

Abstract: A method of decreasing fat and adipose tissue, reducing appetite and increasing alertness in humans comprises administering dihydrolipoamide in a daily dosage between about 300 and 2000 mg. Dihydrolipoamide may be administered once per day or in multiple doses, either alone or in combination with other compounds and mixtures.

Abstract: A method is disclosed for administering naturally occurring chemical Indirubin or its derivatives such as, for example, Indirubin-3?-monoxime, as a method of increasing skeletal muscle mass, decreasing skeletal muscle breakdown and/or decreasing fat mass.

Abstract: A method is disclosed for increasing blood serum levels of dehydroepiandrosterone by administering the combination of one of a flavonoid, isoflavonoid, coumarin and a flavonolignan; dehydroepiandrosterone; and a plant extract.

Abstract: A method is disclosed for administering a DHEA derivative or a physiologically acceptable salt, ester or ether thereof for one of decreasing body weight, reducing adipose tissue, increasing endurance, as an anti-aging compound and generating production of red blood cells.

Abstract: A method of decreasing body weight, reducing adipose tissue and reducing appetite in humans comprises administering a 5-Beta androstane derivative or a physiologically acceptable salt, ester or ether thereof of the general formula: wherein R3 is one of ?-OH , ?-OH, a mixture of ?-OH and , ?-OH, and O; and R7 is one of ?-OH, ?-OH and O.

Abstract: A method of decreasing fat and adipose tissue, and increasing endurance and alertness in humans comprises administering cytisine in a daily dosage between about 0.1 and 8 mg. Cytisine may be administered once per day or in multiple doses, either alone or in combination with other compounds and mixtures.

Abstract: A method of decreasing fat and adipose tissue, and increasing alertness in humans comprises administering epinine in a daily dosage between about 50 and 300 mg. Epinine may be administered once per day or in multiple doses, either alone or in combination with other compounds and mixtures.

Abstract: A method of increasing lean body mass in humans comprises administering a pregnane steroid derivative or a physiologically acceptable salt or ester thereof of the general formula: wherein R1=H and R2=H, or R1 and R2 combined form a single bond; R3 is one of OH and O; R5 is one of an ?-hydrogen and a ?-hydrogen; R6 is one of ?-methyl and H; R7 is one of ?-methyl and H; R17 is one of H and OH; and R20 is one of OH and O.

Abstract: Use of chenodeoxycholic acid is disclosed to reduce adipose tissue and thereby reduce weight in mammals. The chenodeoxycholic acid can be administered orally through the use of a tablet, pill, capsule or liquid suspension.